Aspen Aerogels (ASPN) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Underweight | $5.00 from $4.00 | Aug 11, 2026 |
| Barclays | Maintained | Underweight | $4.00 from $3.00 | May 11, 2026 |
| Barclays | Maintained | Underweight | $3.00 from $4.00 | Mar 5, 2026 |
| TD Cowen | Maintained | Buy | $6.00 from $7.00 | Feb 26, 2026 |
| Roth Capital | Maintained | Buy | $3.00 from $6.00 | Feb 26, 2026 |
| Barclays | Maintained | Underweight | $4.00 from $6.00 | Nov 7, 2025 |
| Canaccord Genuity | Maintained | Buy | $5.00 from $10.00 | Nov 7, 2025 |
| Barclays | Downgraded | Equal-Weight → Underweight | $6.00 from $7.00 | Aug 11, 2025 |
| Canaccord Genuity | Maintained | Buy | $10.00 from $11.00 | Aug 8, 2025 |
| Barclays | Downgraded | Overweight → Equal-Weight | $7.00 from $13.00 | May 29, 2025 |
| Barclays | Maintained | Overweight | $13.00 from $25.00 | Feb 19, 2025 |
| B. Riley Securities | Maintained | Buy | $22.00 from $35.00 | Feb 19, 2025 |
| Craig-Hallum | Maintained | Buy | $18.00 from $21.00 | Feb 14, 2025 |
| Canaccord Genuity | Maintained | Buy | $15.00 from $20.00 | Feb 14, 2025 |
| Roth MKM | Maintained | Buy | $16.00 from $22.00 | Feb 14, 2025 |
| Seaport Global | Downgraded | Buy → Neutral | — | Feb 13, 2025 |
| Canaccord Genuity | Maintained | Buy | $20.00 from $28.00 | Jan 16, 2025 |
| Barclays | Maintained | Overweight | $25.00 from $27.00 | Nov 12, 2024 |
| Roth MKM | Maintained | Buy | $31.00 from $36.00 | Nov 8, 2024 |
| Piper Sandler | Maintained | Overweight | $33.00 from $36.00 | Oct 22, 2024 |
Frequently asked questions
Is ASPN a buy, sell, or hold?
Analysts covering Aspen Aerogels currently average a Buy rating: 3 buy, 1 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on ASPN?
On Aug 11, 2026, Barclays maintained Aspen Aerogels at Underweight with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.